Finance

Beta
Lists
600721:SHA
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CNÂ¥7.79
+10.03%
(+0.71) 1D
Jun 8, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600721...
Open
CNÂ¥7.25
High
CNÂ¥7.79
Low
CNÂ¥7.15
Mkt. cap
2.72B
Avg. vol.
8.66M
Volume
36.95M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 8, 2026
P/E ratio
112.51
52-wk high
CNÂ¥12.60
52-wk low
CNÂ¥6.92
EPS
CNÂ¥0.07
Shares outstanding
400.39M
No. of employees
672
Open
CNÂ¥7.25
High
CNÂ¥7.79
Low
CNÂ¥7.15
Mkt. cap
2.72B
Avg. vol.
8.66M
Volume
36.95M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 8, 2026
P/E ratio
112.51
52-wk high
CNÂ¥12.60
52-wk low
CNÂ¥6.92
EPS
CNÂ¥0.07
Shares outstanding
400.39M
No. of employees
672
News stories
From sources across the web
About Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CEO-
Employees672
Founded1959
Headquarters-
SectorPharmaceutical industry
Websitexjbhc.net
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
105.17M
96.52M
89.71M
67.18M
Cost of goods sold
67.59M
37.13M
85.29M
34.92M
Cost of revenue
67.59M
37.13M
85.29M
34.92M
Research and development expenses
5.98M
5.91M
6.30M
4.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.88M
19.01M
14.60M
15.21M
Operating expense
31.95M
25.37M
16.82M
22.87M
Total operating expenses
99.54M
62.51M
102.11M
57.80M
Operating income
5.63M
34.01M
-12.40M
9.38M
Other non operating income
-77.81K
96.03K
-19.62K
-14.06K
EBT including unusual items
8.66M
8.17M
5.44M
7.26M
EBT excluding unusual items
6.76M
34.94M
-14.36M
10.38M
Income tax expense
3.90M
978.65K
-2.57M
620.69K
Effective tax rate
45.00%
11.98%
-47.26%
8.55%
Other operating expenses
1.21M
1.32M
1.44M
1.40M
Net income
4.76M
7.19M
8.01M
6.64M
Net profit margin
4.53%
7.45%
8.93%
9.89%
Earnings per share
-
-
-
-
Interest and investment income
1.21M
834.46K
-
1.09M
Interest expense
-
-
-1.88M
-79.79K
Net interest expenses
1.21M
834.46K
-1.88M
1.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.98M
38.42M
-7.94M
13.84M
Gain or loss from assets sale
-
-
-884.00
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer